TY - JOUR
T1 - Iron-Based Core-Shell Nanowires for Combinatorial Drug Delivery and Photothermal and Magnetic Therapy.
AU - Martinez Banderas, Aldo
AU - Aires, Antonio
AU - Quintanilla, Marta
AU - Holguin Lerma, Jorge Alberto
AU - Lozano-Pedraza, Claudia
AU - Teran, Francisco J
AU - Moreno Garcia, Julian
AU - Perez, Jose E.
AU - Ooi, Boon S.
AU - Ravasi, Timothy
AU - Merzaban, Jasmeen
AU - Cortajarena, Aitziber L
AU - Kosel, Jürgen
N1 - KAUST Repository Item: Exported on 2020-10-01
Acknowledgements: We thank Irantzu llarena at CIC biomaGUNE for support with confocal microscopy measurements and Sergei Lopatin from the Imaging and Characterization Corel Lab at KAUST.
PY - 2019/11/4
Y1 - 2019/11/4
N2 - Combining different therapies into a single nanomaterial platform is a promising approach for achieving more efficient, less invasive, and personalized treatments. Here, we report on the development of such a platform by utilizing nanowires with an iron core and iron oxide shell as drug carriers and exploiting their optical and magnetic properties. The iron core has a large magnetization, which provides the foundation for low-power magnetic manipulation and magnetomechanical treatment. The iron oxide shell enables functionalization with doxorubicin through a pH-sensitive linker, providing selective intracellular drug delivery. Combined, the core-shell nanostructure features an enhanced light-matter interaction in the near-infrared region, resulting in a high photothermal conversion efficiency of >80% for effective photothermal treatment. Applied to cancer cells, the collective effect of the three modalities results in an extremely efficient treatment with nearly complete cell death (∼90%). In combination with the possibility of guidance and detection, this platform provides powerful tools for the development of advanced treatments.
AB - Combining different therapies into a single nanomaterial platform is a promising approach for achieving more efficient, less invasive, and personalized treatments. Here, we report on the development of such a platform by utilizing nanowires with an iron core and iron oxide shell as drug carriers and exploiting their optical and magnetic properties. The iron core has a large magnetization, which provides the foundation for low-power magnetic manipulation and magnetomechanical treatment. The iron oxide shell enables functionalization with doxorubicin through a pH-sensitive linker, providing selective intracellular drug delivery. Combined, the core-shell nanostructure features an enhanced light-matter interaction in the near-infrared region, resulting in a high photothermal conversion efficiency of >80% for effective photothermal treatment. Applied to cancer cells, the collective effect of the three modalities results in an extremely efficient treatment with nearly complete cell death (∼90%). In combination with the possibility of guidance and detection, this platform provides powerful tools for the development of advanced treatments.
UR - http://hdl.handle.net/10754/660426
UR - https://pubs.acs.org/doi/10.1021/acsami.9b17512
UR - http://www.scopus.com/inward/record.url?scp=85075712874&partnerID=8YFLogxK
U2 - 10.1021/acsami.9b17512
DO - 10.1021/acsami.9b17512
M3 - Article
C2 - 31682404
SN - 1944-8244
VL - 11
SP - 43976
EP - 43988
JO - ACS Applied Materials & Interfaces
JF - ACS Applied Materials & Interfaces
IS - 47
ER -